Social Anxiety Disorder Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Safety, Tolerability, and Efficacy of RLS103 in Subjects With Acute Anxiety Within Social Anxiety Disorder (SAD)
Condition: Social Anxiety Disorder Interventions: Drug: Low dose RLS103; Drug: High dose RLS103; Drug: placebo inhaled dry powder Sponsor: Receptor Life Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2022 Category: Research Source Type: clinical trials
